Immunovant, Inc. (IMVT) Free Cash Flow by Year
Immunovant, Inc. recorded an outflow of $407.3M in free cash flow in fiscal year 2026. This represents a decrease of 8.1% from the prior fiscal year. The table below carries 8 fiscal years, from 2019 to 2026, and the quarters Immunovant, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMVT Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
IMVT Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Immunovant, Inc. financials
Frequently Asked Questions
What was Immunovant, Inc.'s free cash flow in fiscal year 2026?
Immunovant, Inc. recorded an outflow of $407.3M in free cash flow in fiscal year 2026.
How fast is Immunovant, Inc.'s free cash flow growing?
Immunovant, Inc. (IMVT) free cash flow fell by 8.1% year over year, from -$376.6M to -$407.3M in fiscal year 2026.
How has Immunovant, Inc.'s free cash flow changed over the years?
Across the 8 fiscal years this page covers, Immunovant, Inc. (IMVT) free cash flow went from -$28.6M in fiscal year 2019 to -$407.3M in fiscal year 2026.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Immunovant, Inc. (IMVT) reported on that line in every period on record.